Owkin launch­es new start­up to ‘cap­ture laws of bi­ol­o­gy’ with $35M seed round

Sci­en­tists from AI biotech Owkin and Google Deep­Mind have come to­geth­er to form Biop­ti­mus, a nascent French start­up work­ing to cre­ate an AI foun­da­tion­al mod­el for bi­ol­o­gy. It’s start­ing with $35 mil­lion in seed fi­nanc­ing, as dis­closed Tues­day morn­ing.

The goal is to help re­searchers, da­ta sci­en­tists, biotechs, phar­ma­ceu­ti­cal com­pa­nies and oth­ers in the bio­med­ical and en­vi­ron­men­tal sci­ences com­mu­ni­ties to gain a more thor­ough un­der­stand­ing of bi­ol­o­gy to make bet­ter med­i­cines and di­ag­nos­tic tools, among oth­er in­no­va­tions, gen­er­al man­ag­er and co-founder David Ca­hané said in an in­ter­view with End­points News. He’s al­so chief so­lu­tions of­fi­cer at Owkin.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER